Kura Oncology Insider Trades
NASDAQ: KURAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 2 · $2.35M
- Sales
- 35 · $3.34M
- Shares bought / sold
- 200.00K / 323.46K
- Net activity
- Net selling $992,945
Kura Oncology insider activity
Over the last 12 months, Kura Oncology insiders reported 47 transactions on SEC Form 4: 2 open-market purchases and 35 sales. Insiders bought $2.4 million and sold $3.3 million worth of stock, for net insider selling of $992,945. The largest seller was Leoni Mollie, with $1.3 million in reported sales.
The most recent filing shows Leoni Mollie (Chief Medical Officer) selling 28,802 shares at $10.75 on Sep 29, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put KURA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
KURA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 29, 2026 | Powl Brian T.Chief Commercial Officer | Sale | 15,430 | $165.85K | Form 4 |
| Sep 29, 2026 | FORD KATHLEENChief Operating Officer | Sale | 3,668 | $39.44K | Form 4 |
| Sep 29, 2026 | Leoni MollieChief Medical Officer | Sale | 28,802 | $309.57K | Form 4 |
| Sep 28, 2026 | Powl Brian T.Chief Commercial Officer | Sale | 8,000 | $84.50K | Form 4 |
| Sep 28, 2026 | Powl Brian T.Chief Commercial Officer | Sale | 9,020 | $94.69K | Form 4 |
| Sep 28, 2026 | DOYLE THOMAS JAMESSVP, Finance & Accounting | Sale | 4,607 | $48.36K | Form 4 |
| Sep 28, 2026 | FORD KATHLEENChief Operating Officer | Sale | 6,906 | $72.49K | Form 4 |
| Sep 28, 2026 | Bair Teresa BrophyChief Legal Officer | Sale | 8,442 | $88.62K | Form 4 |
| Sep 28, 2026 | Leoni MollieChief Medical Officer | Sale | 12,448 | $130.67K | Form 4 |
| Sep 24, 2026 | Burrows FrancisChief Scientific Officer | Sale | 20,726 | $224.51K | Form 4 |
| Sep 24, 2026 | Burrows FrancisChief Scientific Officer | Option exercise | 30,000 | $184.50K | Form 4 |
| Aug 24, 2026 | WILSON TROY EDWARDPresident and CEO | Buy | 100,000 | $1.24M | Form 4 |
| Aug 21, 2026 | Powl Brian T.Chief Commercial Officer | Sale | 4,345 | $51.66K | Form 4 |
| Aug 19, 2026 | Bair Teresa BrophyChief Legal Officer | Sale | 31,487 | $397.68K | Form 4 |
| Aug 17, 2026 | WILSON TROY EDWARDPresident and CEO | Buy | 100,000 | $1.11M | Form 4 |
| Jun 18, 2026 | Leoni MollieChief Medical Officer | Sale | 84,929 | $834.28K | Form 4 |
| May 21, 2026 | Powl Brian T.Chief Commercial Officer | Sale | 10,000 | $110.00K | Form 4 |
| May 19, 2026 | Powl Brian T.Chief Commercial Officer | Sale | 339 | $3.12K | Form 4 |
| May 19, 2026 | FORD KATHLEENChief Operating Officer | Sale | 2,257 | $20.48K | Form 4 |
| May 18, 2026 | Bair Teresa BrophyChief Legal Officer | Sale | 2,256 | $21.16K | Form 4 |
| Mar 23, 2026 | WILSON TROY EDWARDPresident and CEO | Option exercise | 6,103 | $37.53K | Form 4 |
| Mar 18, 2026 | Malley ThomasDirector | Option exercise | 10,000 | $31.20K | Form 4 |
| Jan 27, 2026 | Bair Teresa BrophyChief Legal Officer | Sale | 4,777 | $40.42K | Form 4 |
| Jan 27, 2026 | Bair Teresa BrophyChief Legal Officer | Sale | 2,335 | $19.76K | Form 4 |
| Jan 27, 2026 | Bair Teresa BrophyChief Legal Officer | Sale | 4,096 | $34.66K | Form 4 |
| Jan 27, 2026 | DOYLE THOMAS JAMESSVP, Finance & Accounting | Sale | 881 | $7.45K | Form 4 |
| Jan 27, 2026 | DOYLE THOMAS JAMESSVP, Finance & Accounting | Sale | 2,226 | $18.83K | Form 4 |
| Jan 27, 2026 | DOYLE THOMAS JAMESSVP, Finance & Accounting | Sale | 695 | $5.88K | Form 4 |
| Jan 27, 2026 | DOYLE THOMAS JAMESSVP, Finance & Accounting | Sale | 1,114 | $9.43K | Form 4 |
| Jan 27, 2026 | DOYLE THOMAS JAMESSVP, Finance & Accounting | Sale | 2,226 | $18.83K | Form 4 |
| Jan 27, 2026 | Leoni MollieChief Medical Officer | Sale | 1,341 | $11.35K | Form 4 |
| Jan 27, 2026 | Leoni MollieChief Medical Officer | Sale | 951 | $8.05K | Form 4 |
| Jan 27, 2026 | Leoni MollieChief Medical Officer | Sale | 2,233 | $18.89K | Form 4 |
| Jan 27, 2026 | Leoni MollieChief Medical Officer | Sale | 3,655 | $30.92K | Form 4 |
| Jan 27, 2026 | Powl Brian T.Chief Commercial Officer | Sale | 1,572 | $13.30K | Form 4 |
| Jan 27, 2026 | Powl Brian T.Chief Commercial Officer | Sale | 4,842 | $40.97K | Form 4 |
| Jan 27, 2026 | Burrows FrancisChief Scientific Officer | Sale | 1,311 | $11.09K | Form 4 |
| Jan 27, 2026 | FORD KATHLEENChief Operating Officer | Sale | 1,813 | $15.34K | Form 4 |
| Jan 2, 2026 | Powl Brian T.Chief Commercial Officer | Award | 50,000 | — | Form 4 |
| Jan 2, 2026 | FORD KATHLEENChief Operating Officer | Award | 50,000 | — | Form 4 |
| Jan 2, 2026 | Bair Teresa BrophyChief Legal Officer | Award | 50,000 | — | Form 4 |
| Jan 2, 2026 | Leoni MollieChief Medical Officer | Award | 50,000 | — | Form 4 |
| Jan 2, 2026 | DOYLE THOMAS JAMESSVP, Finance & Accounting | Award | 21,250 | — | Form 4 |
| Dec 18, 2025 | Burrows FrancisChief Scientific Officer | Sale | 23,726 | $231.93K | Form 4 |
| Dec 18, 2025 | Burrows FrancisChief Scientific Officer | Option exercise | 35,000 | $168.00K | Form 4 |
| Dec 9, 2025 | Hasnain FaheemDirector | Sale | 10,000 | $109.76K | Form 4 |
| Dec 9, 2025 | Hasnain FaheemDirector | Option exercise | 10,000 | $31.20K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4